Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2014135655) COMPOSITIONS AND METHODS FOR TREATING MUSCLE-INVASIVE BLADDER CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2014/135655 International Application No.: PCT/EP2014/054384
Publication Date: 12.09.2014 International Filing Date: 06.03.2014
IPC:
C12Q 1/68 (2006.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Q
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1
Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
68
involving nucleic acids
Applicants:
INSTITUT CURIE [FR/FR]; 26 rue d'Ulm F-75248 Paris cedex 05, FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE [FR/FR]; 3 rue Michel Ange F-75016 Paris, FR
Inventors:
RADVANYI, François; FR
REBOUISSOU, Sandra; FR
KAMOUN, Aurélie; FR
ALLORY, Yves; FR
DE REYNIES, Aurélien; FR
BERNARD-PIERROT, Isabelle; FR
LEBRET, Thierry; FR
Agent:
PIERRU, Bénédicte; Becker & Associes 25, rue Louis le Grand 75002 Paris, FR
Priority Data:
13305253.006.03.2013EP
Title (EN) COMPOSITIONS AND METHODS FOR TREATING MUSCLE-INVASIVE BLADDER CANCER
(FR) COMPOSITIONS ET MÉTHODES DE TRAITEMENT DU CANCER DE LA VESSIE INVASIF POUR LE MUSCLE
Abstract:
(EN) The present invention relates to a method to classify patients suffering from a muscle-invasive bladder cancer for therapeutic intervention, in particular for selecting a patient afflicted with a muscle-invasive bladder cancer for a treatment comprising an EGFR kinase inhibitor and/or capecitabine.
(FR) La présente invention concerne un procédé pour classifier des patients souffrants du cancer de la vessie invasif pour le muscle pour une intervention thérapeutique, en particulier pour la sélection d'un patient atteint du cancer de la vessie invasif pour le muscle pour un traitement comprenant un inhibiteur de kinase EGFR et/ou de capécitabine.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)